Effects of selenium on chemical carcinogens.
D015073:2-Acetylaminofluorene / Q000037:antagonists & inhibitors; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D001205:Ascorbic Acid / Q000494:pharmacology; D002084:Butylated Hydroxytoluene / Q000627:therapeutic use; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D004127:Dimethylhydrazines / Q000037:antagonists & inhibitors; D006881:Hydroxyacetylaminofluorene / Q000494:pharmacology; D066298:In Vitro Techniques; D008113:Liver Neoplasms; D008297:Male; D008746:Methylazoxymethanol Acetate / Q000037:antagonists & inhibitors; D009154:Mutation / Q000187:drug effects; D009369:Neoplasms / Q000139:chemically induced*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D051381:Rats; D012643:Selenium / Q000494:pharmacology*; D012854:Sister Chromatid Exchange / Q000187:drug effects; D004124:p-Dimethylaminoazobenzene / Q000037:antagonists & inhibitors
D002273:Carcinogens; D004127:Dimethylhydrazines; D002084:Butylated Hydroxytoluene; D006881:Hydroxyacetylaminofluorene; D008746:Methylazoxymethanol Acetate; D015073:2-Acetylaminofluorene; D004124:p-Dimethylaminoazobenzene; D001189:Aryl Hydrocarbon Hydroxylases; D012643:Selenium; D001205:Ascorbic Acid